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Abstract The aim of this pilot study was to investigate
the feasibility and effectiveness of a new psychoeducative
intervention program (PEGASUS) for adults with ADHD
and their significant others in a psychiatric outpatient
context. At three outpatient psychiatric clinics, adults with
ADHD and their significant others took part in PEGASUS,
a psychoeducational program based on theories from cog-
nitive behavioral therapy, neuropsychology, and cross-
disciplinary evidence regarding ADHD. In total, 108 adults
were allocated to treatment (51 with ADHD and their 57
significant others). Feasibility was evaluated regarding
suitability of the intervention at a psychiatric outpatient
clinic and treatment completion. Preliminary efficacy was
evaluated per protocol from baseline to post-intervention
(n = 41 adults with ADHD and 40 significant others). In a
feasibility analysis, the intervention was judged to be a
suitable treatment option for 94.5 % of all individuals with
a primary diagnosis of ADHD at an outpatient psychiatric
clinic. In total, 43 out of 51 allocated individuals with
ADHD (84.3 %) completed the intervention. The corre-
sponding figures for their significant others were 42 out of
57 (73.7 %). Knowledge about ADHD increased, and both
the quality of relationships and psychological well-being
improved from baseline to post-intervention in all partici-
pants. The significant others reported a reduction in the
subjective burden of care, such as worry and guilt. The
objective burden of care (such as financial problems) did
not change. The findings support the potential value of
psychoeducation for adults with ADHD and their signifi-
cant others. An ongoing randomized controlled trial will
generate further evidence concerning the PEGASUS
program.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is an
early-onset neurodevelopmental disorder characterized by
profound difficulties with inattention, hyperactivity, and
impulsivity (American Psychiatric Association 2013). In
the majority of cases, ADHD persists into adulthood
(Spencer et al. 2007), and the cross-national prevalence
rate has been estimated to 3.4 %, assessed in Belgium,
Colombia, France, Germany, Italy, Lebanon, Mexico, the
Netherlands, Spain, and the USA (Fayyad et al. 2007).
Adult ADHD is often accompanied by a heightened sus-
ceptibility to various stressors and is associated with per-
vasive impairments across multiple domains of life, such as
mental and physical health, education, work, economy,
social life, family living, and parenting (Barkley 2002;
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Bolte et al. 2013; Brod et al. 2006; Goodman 2007; Hir-
vikoski et al. 2009). The clinical picture is often further
complicated by the presence of additional comorbid psy-
chiatric conditions (Fayyad et al. 2007; McGough et al.
2005; Sobanski et al. 2007).
It has been suggested that the often strained relation-
ships between adults with ADHD and their spouses, family
members, friends, and co-workers may result from a
combination of mutual, long-term frustration with the
symptoms and a lack of understanding of the disorder
(Goodman 2007; Moss et al. 2007). Adults with ADHD
often struggle with significant difficulties involving emo-
tional regulation (Retz et al. 2012), and their partners and
family members often complain about them being forget-
ful, overreactive, and poor at listening (Murphy 2005).
Significant others frequently feel overburdened by the
responsibilities of taking care of their family member with
ADHD (Cadman et al. 2012; Murphy 2005).
Knowledge pertaining to ADHD is generally low in
society at large, and individuals with ADHD, as well as
those close to them, are at high risk of being confronted
with stigma, prejudices, and discrimination (Mueller et al.
2012). Without an adequate explanation to make sense of
their difficulties, individuals with ADHD may perceive
ADHD-related misbehaviors as reflecting personal flaws
rather than their disorder (Fleischmann and Fleischmann
2012; Young et al. 2008). Before coming to terms with the
established ADHD diagnosis, it is not uncommon to
encounter emotional turmoil and confusion characterized
by negative thoughts and rumination (Young et al. 2008).
Clinical guidelines recommend integrating pharmaco-
logical and psychosocial interventions in the treatment of
adult ADHD (CADDRA 2008; Ebert et al. 2003; NICE
2009; Practice Parameters 1997). During the last decade,
some controlled trials have found cognitive behavioral
therapies (CBTs, such as cognitive therapy, dialectical
behavioral therapy, and meta-cognitive therapy) to be a
promising treatment strategy for adults with ADHD (Em-
ilsson et al. 2011; Hirvikoski et al. 2011; Philipsen et al.
2013; Safren et al. 2010; Solanto et al. 2010; Stevenson
et al. 2002). However, CBTs often put high demands on the
participants’ motivation, skills, and stamina and thus may
not be a suitable option for all individuals in all phases of
the care process (Hirvikoski et al. 2011).
Often offered in addition to the standard medical care,
psychoeducation is a well-established, evidence-based
intervention for several psychiatric disorders in adulthood
(Murray-Swank and Dixon 2004). Psychoeducational
interventions are aimed at empowering patients and their
significant others with knowledge and directly ask patients
to share in their own treatment (Hayes and Gantt 1992).
While the efficacy of psychoeducational family programs
targeting children and adolescents with ADHD has gained
support (Montoya et al. 2011), research into psychoedu-
cation for adults with ADHD is still surprisingly scarce.
Moreover, the only study published on psychoeducation for
adults with ADHD did not involve significant others and
resulted in multifaceted findings, indicating positive effects
on, for example, disorganization, inattention, and emo-
tional liability, but also potentially negative effects on self-
esteem (Wiggins et al. 1999).
We are currently evaluating a manualized psychoedu-
cational program (PEGASUS) (Hirvikoski et al. 2013a)
designed as an initial nonpharmacological treatment option
after receiving an ADHD diagnosis in adulthood. The aim
of the present open clinical trial was to do a pilot study on
the feasibility and preliminary effectiveness of the PEG-
ASUS program in a psychiatric outpatient setting. A further
aim was to gather feedback from participants and course
group leaders that could be used to improve and fine-tune
PEGASUS prior to a randomized controlled study.
Methods
The intervention was conducted as part of the clinical
routine at two outpatient tertiary psychiatric clinics for the
assessment and treatment of adults with neurodevelop-
mental disorders (Neuropsychiatric Unit Karolinska, Psy-
chiatry Northwest, and Neuropsychiatric Unit, Psychiatry
Southwest, Stockholm County Council) and one outpatient
psychiatric clinic (Liljeholmen Outpatient Psychiatric
Clinic, Psychiatry Southwest, Stockholm County Council).
The study was approved by the Regional Ethics Committee
of Stockholm (2009/824-31/3).
Participants
Participants were recruited from the patient base of the
three psychiatric clinics involved in the study. The ADHD
diagnostic assessment was performed before the participant
entered the study and was based on clinical practice in
Stockholm County Council clinics at the time of the study.
Multiple sources of information were combined to consti-
tute a consensus between the clinicians involved in the
assessment. A clinical interview based on the DSM-IV-TR
criteria (American Psychiatric Association 2000) was
conducted, and patients completed standardized self-rating
questionnaires, such as the Wender Utah Rating Scale
(WURS) (Ward et al. 1993) for the assessment of child-
hood ADHD symptoms and the Adult ADHD Self-Report
Scale (ASRS) (Adler et al. 2006) for the assessment of
ADHD symptoms in adulthood. The clinical routine
involved collecting collateral information from significant
others (possible in 88 % of cases in the present study
sample), using clinical interviews and/or questionnaires in
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order to obtain multiperspective diagnostic information on
each individual. When available, additional information
was obtained from records from child and adolescent
psychiatry units and school health services, as well as adult
psychiatry services. In most cases, the assessment also
included psychological testing, such as estimations of
general cognitive capacity (Wechsler 1997) and urine drug
screening.
In order to include a sample reflecting the natural het-
erogeneity of the adult ADHD population presenting in an
outpatient psychiatric context, the inclusion criteria for the
study were broad: ADHD as the primary (neurodevelop-
mental) diagnosis; age of 18 years or older; possibility to
participate with at least one adult significant other. The
exclusion criteria were as follows: current substance abuse
(during the previous 3 months); mental retardation
(IQ B 70); organic brain injury; autism spectrum disorder;
suicidality; any other severe psychiatric disorders (e.g.,
psychosis); or adverse psychosocial circumstances (e.g.,
being homeless), thus making successful participation
unlikely or impossible. Ongoing pharmacological treat-
ment was not a reason for exclusion.
Recruitment process and enrollment of participants
The first contact with the ADHD participants was estab-
lished by sending out study information letters. Thereafter,
they were invited to visit the clinic in small groups for
further information and for judging the inclusion criteria
individually. All participants gave their written informed
consent before completing the questionnaires. An experi-
enced clinician (the course coordinator or a professional
under the supervision of the course coordinator) conducted
individual interviews and studied case files in order to
further assess eligibility. Participants with ADHD were
instructed to participate with at least one significant other
with whom they had a relationship in their everyday lives.
The significant others completed the questionnaires at
home after having received a written rationale and
instructions.
Psychoeducational program
The PEGASUS program for adults with ADHD and their
significant others is a highly structured manualized psy-
choeducational intervention designed to constitute a first
nonpharmacological intervention after the establishment of
an ADHD diagnosis at adult age (Hirvikoski et al. 2013a).
The overarching goal of the treatment is to increase the
participant’s knowledge of ADHD that may facilitate the
management of ADHD in daily life. The information
Table 1 Themes and main focuses
Themes and main focuses of the
eight course evenings
The lecturer recruited by the
course group leader
1. Introduction to ADHD in
adulthood: Gives the
participants a joint, basic
understanding of the ADHD
diagnosis, as well as of
common difficulties (including
psychiatric comorbidity) and
strengths for individuals with
ADHD
The first lecture should
preferably be given by the







experienced in the treatment of
ADHD in adults
3. Lifestyle factors: sleep, stress,
diet, and exercise: Focuses on
the connection between general
lifestyle factors (such as sleep
and physical activity) and
ADHD symptom severity
Psychologist, occupational
therapist, nurse, or other
professional experienced in the
theme of the lecture
4. Structure and strategies in
everyday life: Presents a range
of strategies and cognitive aids




experienced in ADHD in adults
5. Living with ADHD—
acceptance and change:
Focuses on life with ADHD, as
experienced and related by an
individual having received the
diagnosis as an adulta
An individual with an ADHD
diagnosis
6. ADHD in relationships:
Focuses on how ADHD
symptoms, such as inattention
and impulsivity, may affect
social behaviors and close
relationships. Both positive and
negative aspects of ADHD in
relationships are discussed from
the perspectives of adults with
ADHD and significant others
Psychologist, social worker or
other professional experienced
in the theme of the lecture
7. ADHD at work: Informs about
the various support measures
provided by the employment
services and on how job
assignments/the workplace may
be adjusted based on ADHD
symptoms
Guest lecturer(s) from local
employment services and
psychologist, occupational
therapist or other professional
experienced in ADHD in the
workplace
8. Service and support provided
by society: Informs about the
various support measures
society may provide individuals
with ADHDa
Guest lecturer from local
municipality services, social
worker or other experienced
professional
a A representative from the interest organization Attention informs
briefly about their work in conjunction with course session 5 or 8
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covered not only knowledge of ADHD as such but also
different strategies, treatments, and support options pro-
vided by psychiatric care and other organizations in soci-
ety. Further goals are to improve the quality of the
relationship between the co-participants (i.e., between the
individuals with ADHD and their participating significant
other(s)) in order to reduce the burden of care on the par-
ticipating significant others, to increase acceptance of the
ADHD diagnosis, to promote belief in finding relief, and to
improve the quality of life of the participants.
The program is based on general principles taken from
CBT, neuropsychology, and cross-disciplinary clinical
evidence pertaining to ADHD. Several experienced psy-
chologists, psychiatrists, and occupational therapist have
contributed to the contents of the program. Following
training in the general principles of the intervention, the
group leaders were responsible for the staging of the course
at the participating clinics. The group leaders were pro-
vided with a preliminary version of the workbook (Hir-
vikoski et al. 2013a), as well as with all materials needed
for the implementation of the intervention, such as lecture
materials, instructions for lecturers at different sites,
informative material for the recruitment.
The PEGASUS program comprises eight sessions in a
closed group, including both participants with ADHD and
their significant others (Table 1). Each session lasts for
2.5 h and includes a 30-minute break (with coffee/tea and
sandwiches). The group leaders accompany the group from
the recruitment to the follow-up measures and serve as
contact persons for both participants and lecturers. Dif-
ferent lecturers are recruited from the local clinic by the
group leader. The lecturers, all with long-standing experi-
ence of and expertise in the different course themes
(Table 1), are provided with preprepared lecture materials,
including power point and planned themes for small group
discussions that are organized during the lectures.
The lecturers are informed both orally and in writing
about the general goals and principles of the intervention.
The group leader actively strives to support the lecturer so
as to keep the intervention in line with the intended general
principles. Thus, the focus on psychoeducation (not family
counseling, psychotherapy, or individual problem solving)
is stressed. Negative experiences, such as school failure or
past substance abuse, should be validated while rumination
and dwelling on the past are avoided (Young et al. 2008).
The preprepared lecture material and the course coordi-
nator support the lecturers in giving their lectures in an
empowering and validating spirit, discussing difficulties
and disabilities, but also highlighting possibilities for
change as well as pointing out common strengths in indi-
viduals with ADHD, thus applying techniques of accep-
tance. The lecturers are also provided with various
pedagogical tips to help them give the lectures in an
ADHD-friendly way, e.g., facilitating sustained attention
and learning process in different ways.
At the time of the present study, the workbook for
participants (Hirvikoski et al. 2013b) was not yet pub-
lished. Instead, all participants received a folder to collect
and organize information and handouts. The folder served
as a workbook and compendium to make the course
material available at home between the sessions and after
completing the course.
Group sizes
The PEGASUS intervention is designed to be carried out in
relatively large psychoeducational groups. The group sizes
in the present study ranged between 20 and 30 individuals,
approximately half of each group consisting of adults with
ADHD and half of their significant others. In total, four
psychoeducational groups were conducted.
Measures
Background and demographic data
Case histories and socio-demographic data on participants
with ADHD were extracted from their clinical files.
Moreover, they completed a questionnaire covering
demographic information and current stressors in different
areas of life (Hirvikoski et al. 2009). A modified version of
this questionnaire was used to assess the background and
demographic data of the significant others.
Outcome measures
In the present open pilot study, the main assessments
regarded feasibility. Moreover, efficacy-related measures
were included for a preliminary estimation of treatment
effects. Self-rating questionnaires were distributed at
baseline of 1–2 weeks before the intervention started (T1),
at post-treatment of 1–2 weeks after the last session (T2),
and at follow-up of 6 months after the intervention had
ended (T3).
Feasibility
Two criteria were used to evaluate feasibility: (1) the
psychoeducative program should be regarded as a suitable
intervention for at least 90 % of all individuals assessed
with ADHD, as judged in a consecutive cohort from one of
the participating clinics by a senior clinical psychologist
involved in the project (EW); and (2) a dropout rate of
\25 % (i.e., a clear majority should complete the program
and thus attend at least 50 % of the sessions). Treatment
92 T. Hirvikoski et al.
123
satisfaction was evaluated for the entire psychoeducational
program, using a modified version of the patient evaluation
form (Hesslinger et al. 2002, 2004, 2010; Hirvikoski et al.
2011; Philipsen et al. 2007), scored on a Likert scale
ranging from 0 (‘‘I disagree’’) to 4 (‘‘I strongly agree’’), and
completed anonymously at the end of the last session. The
participants also rated the course as a whole following the
school grading system ‘‘Failed,’’ ‘‘Passed,’’ ‘‘Passed with
distinction,’’ and ‘‘Passed with special distinction’’ (scored
0–3 in the database). To get feedback on each course
session for further development of the program, the par-
ticipants also completed the session evaluation form (SEF)
(Bramham et al. 2009), modified for the current study. The
SEF was completed anonymously at the end of each course
session.
Efficacy-related measures
All participants completed the ADHD 20 Questions, a
knowledge quiz with 20 true/false scored items, reflecting
knowledge about ADHD and modified for this study from
a corresponding scale (Bramham et al. 2009). Further-
more, all participants completed the questions about
family members (QAFM) (Hansson and Jarbin 1997). The
QAFM is a dyadic self-report questionnaire (completed
with respect to each relationship if the adult with ADHD
participated with more than one significant other) that was
used to measure aspects of the quality of the relationship
between the co-participants (that is, between the adult
individual with ADHD and his/her significant other[s]).
The QAFM comprises four subscales (Hansson and Jarbin
1997): (1) critical remarks (critical remarks directed at the
other person); (2) (the respondent’s) emotional overin-
volvement; (3) perceived criticism from the other person;
and (4) perceived emotional involvement from the other
person in the relationship. The thirty items are scored on a
5-point Likert scale from 1 (‘‘almost never’’) to 5 (‘‘almost
always’’). Low scores on the first three subscales are
indicative of a good quality of relationship, while on the
last subscale (Emotional Involvement), high scores indi-
cate the same. Symptoms of depression were measured
using the Beck Depression Inventory (BDI) Beck et al.
(1961, 1988b), symptoms of anxiety using the Beck
Anxiety Inventory (BAI) (Beck et al. 1988a), and sub-
jective stress using the Swedish version of the Perceived
Stress Scale (PSS) (Cohen et al. 1983; Eskin and Parr
1996).
In participants with ADHD, self-esteem was investi-
gated using Rosenberg’s Self-Esteem (RSE) Scale
(Rosenberg 1965), and quality of life using the Adult
Attention Deficit/Hyperactivity Disorder Quality-of-Life
(AAQoL) Scale (Brod et al. 2006). The twenty-nine items
of the AAQoL are scored from 1 (‘‘Not at all/Never’’) to 5
(‘‘Extremely/Very often’’) and summarized to give an
overall score.
In significant others, the burden of care was assessed
using the Burden Assessment Scale (BAS) (Reinhard et al.
1994), which has two subscales (1) Subjective Burden,
such as caregiver’s emotional responses, and (2) Objective
Burden, such as financial problems. The scale consists of
19 items scored on a 4-point Likert scale from 1 (‘‘Not at
all’’) to 4 (‘‘A lot’’).
Statistical analysis
Most continuous scales used to assess outcome were nor-
mally distributed. However, the BDI and the BAI showed
positively skewed distributions due to many low scores
(especially among significant others). The results were
similar using nonparametric versus parametric statistical
methods and, for the sake of brevity, we chose to report
results from the parametric methods only. Outliers were
screened for using boxplots. One of the three clinics/sites
was not able to perform the T3 assessments due to changes
in staffing. In conjunction with individuals not reached for
T3 measurements at the other sites, the T3 data were
missing for one third of the study groups. Therefore, the
data were only analyzed from T1 (baseline) to T2 (post-
intervention). For cases (n = 6 out of 81, 7.4 %) missing
T2 but having T3 (follow-up at 6 months), we imputed the
T3 score instead of the missing T2. Thus, the main statis-
tical analyses were performed on all participants who (1)
completed the treatment, i.e., were present at at least 4 out
of 8 sessions and (2) had T2 or T3 data. Among these
individuals (n = 81), baseline data were missing for four
cases on the ADHD 20 Questions and one case on the PSS.
The treatment mean imputation (TMI) (Crowe et al. 2010)
was used to replace these data. The efficacy-related mea-
sures were analyzed using a series of repeated measures
ANOVAs (rmANOVAs), with a baseline score (T1), and
post-intervention score (T2, if missing, imputed with the
T3 score) as a within-subjects repeated measure factor, and
group (ADHD versus significant other) as a between-sub-
jects factor. In this way, we also analyzed whether or not
the two groups responded differently to the intervention, as
would be indicated by group-by-time interaction effects.
When indicated by the Mauchly’s test of sphericity, the
rmANOVAs were corrected for violence against an
assumption of sphericity using the Huyn-Feldt correction.
The effect size was expressed as partial eta squared (g2) for
efficacy-related measures and was interpreted using the
guidelines proposed by Cohen: 0.01 = small effect size,
0.06 = moderate effect size, and 0.14 = large effect size
(Cohen 1988). The alpha levels were set at p B 0.05 for
significance and at p B 0.10 for a statistical trend.
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Results
Background and demographic data
Background and demographic data are described in
Table 2 for participants with ADHD and in Table 3 for
significant others.
Feasibility
The first criterion for feasibility was judged at the Neuro-
psychiatric Unit Karolinska, where 144 individuals were
diagnosed during the years 2004–2008 with ADHD as their
main neurodevelopmental diagnosis. The psychoeduca-
tional program was estimated to be a suitable intervention for
136 (94.5 %) of the individuals in this consecutive cohort.
The flowchart for the present study group is presented in
Fig. 1. In total, 43 out of the 51 allocated individuals with
ADHD (84.3 %) completed the intervention. The corre-
sponding figures for the significant others were 42 out of 57
(73.7 %).
The mean scores (±1 standard error) on the patient
evaluation form are shown in Fig. 2. The overall treatment
satisfaction was good among both individuals with ADHD
and their significant others. However, the participants with
ADHD rated significantly higher than their significant
others on the items ‘‘The course was clearly related to
ADHD’’ (p = 0.007) and ‘‘I would attend a similar course
in the future’’ (p = 0.03). The rating of the whole course
according to the school grading system did not differ
between the groups (M = 2.21, SD = 0.72, corresponding
to ‘‘Passed with distinction’’). The feedback on each course
occasion was summarized in writing for the purpose of
further development of the PEGASUS program.
Efficacy-related measures
The mean values and standard deviations for question-
naires administered to all participants at baseline as well as
post-intervention are depicted in Table 4. The results
Table 2 Characteristics of participants with ADHD (n = 41)
Age M = 37.56, SD = 10.43
Range 20–63
Sex 26 males (63.41 %)
ADHD subtype ADHD combined: 31 (75.60 %)
ADHD inattentive: 10 (24.39 %)
Years diagnosed with
ADHD
Less than 12 months: 23 (56.10 %)
\2 years: 6 (14.63 %)
\3 years: 3 (7.32 %)
\4 years: 4 (9.76 %)
\5 years: 2 (4.88 %)
\6 years: 3 (7.32 %)
Pharmacological treatment
of ADHD
n = 22 (53.66 %)
Any psychoactive drug n = 31 (75.61 %)
At least one comorbid
DSM-IV diagnosis
n = 27 (65.85 %)
Employment Full-time work, studying or parental
leave: 24 (58.54 %)
Part-time work, studying or parental
leave: 4 (9.76 %)
Unemployed: 3 (7.32 %)
Long-term sick leave or disability
pension: 10 (24.39 %)
Education University: 10 (24.39 %)
Upper secondary school: 23 (56.10 %)
Nine-year compulsory school or less: 5
(12.50 %)
Other: 2 (4.88 %)
Full-scale IQa M = 96.53, SD = 13.91, range:
76–124
WURS-25 scorea M = 53.06, SD = 17.13
ASRSa M = 47.25, SD = 13.26
a Data extracted from the previous diagnostic assessment and avail-
able for 26 (63.41 %) for full-scale IQ; 33 (80.49 %) for WURS-25
score (Wender Utah Rating Scale), and 28 (68.29 %) for ASRS
Table 3 Characteristics of participating significant others (n = 40)
Age M = 48.48, SD = 15.00
Range: 20–73
Sex 16 males (40 %)
Employment Full-time work or studying:
30 (75 %)
Part-time work: 2 (5 %)
Retired: 5 (12.50 %)
Unemployed: 1 (2.50 %)
Long-term sick leave or
disability pension: 2
(5.00 %)
Education University: 18 (45 %)
Upper secondary: 16 (40 %)
Nine-year compulsory school
or less: 5 (12.50 %)
Other: 1 (2.50 %)
Relation to the participant with
ADHD
Partner: 19 (47.50 %)
Parent: 18 (45 %)
(Grown-up) child: 2 (5 %)
Close friend: 1 (2.50 %)
Living in the same household as the
participant with ADHD
Yes: 31 (77.50 %)
Involved in the diagnostic assessment
of the participants with ADHD
Yes: 30 (75 %)
Member of any ADHD interest
organization or advocacy group
Yes: 3 (7.50 %)
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indicated positive improvements in knowledge about
ADHD, relationship quality (the QAFM Critical Remarks
Subscale), psychological well-being (BDI and BAI), and
subjective stress (PSS) over time. The only significant
interaction effect was observed in the ADHD knowledge
quiz and indicated a somewhat larger increase in knowl-
edge in the significant others from baseline to post-inter-
vention (F(1,79) = 19.91, g
2 = 0.06, p \ 0.05).
In questionnaires completed by the adults with ADHD, a
trend toward improvement of self-esteem was observed in
RSE (F(1,40) = 3.75, g
2 = 0.09, p = 0.06), while the
increase in the AaQoL score did not reach statistical sig-
nificance or trend (g2 = 0.05, p = 0.15).
On the the Burden Assessment Scale (BAS), completed
by the significant others, a significant decrease was
observed in the subjective burden (p \ 0.01), while no
changes occurred in the objective burden from baseline to
post-intervention (Table 5).
Discussion
A new manualized psychoeducational program for adults
with ADHD and their significant others, PEGASUS (Hir-
vikoski et al. 2013a), was evaluated in an open study
design regarding feasibility and preliminary efficacy. An
•
•
Fig. 1 Flowchart for the study group including adults with ADHD and their significant others (SO)
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additional aim was to gather feedback that could be used to
inspire and sustain further development of the program
before a randomized controlled trial was to be undertaken.
The PEGASUS program was designed to constitute a
first psychological intervention after the establishment of
an ADHD diagnosis, while the more demanding behavioral
therapeutic treatments are planned for later on in an opti-
mized treatment pathway. The psychoeducational program
was judged to be a suitable treatment option for 94.5 % of
adults with ADHD in an outpatient psychiatric context.
Treatment suitability was judged for the adults with ADHD
only. In the present study, their significant others were
included routinely. Since the PEGASUS program is the
first manualized psychological treatment for adults with
ADHD that also involves their significant others, one of the
challenges was to make the program acceptable and ben-
eficial for all participants—regardless of diagnostic status.
The overall treatment satisfaction was good in both groups.
However, there were also slight differences between the
adults with ADHD and their significant others, namely,
adults with ADHD valued the program slightly more in
Fig. 2 Treatment satisfaction such as measures with patient evalu-
ation form
Table 4 Results of repeated
measures ANOVAs from
baseline to post-intervention for
questionnaires completed by
both adults with ADHD and
their significant others
QAFM Questions About Family
Member questionnaire
Outcome measures Baseline Post- intervention rmANOVA statistics p value
Mean (SD) Mean (SD) F (df) g2effect size
ADHD-20 questions
Adults with ADHD 15.76 (2.26) 16.27 (1.82) F(1,79) = 19.91 p \ 0.001
Significant others 14.60 (2.36) 16.18 (1.84) g2 = 0.20
QAFM perceived criticism
ADHD 14.16 (5.37) 14.13 (4.79) F(1,82) = 0.51 ns
Significant others 13.38 (4.63) 12.85 (4.52) g2 \ 0.01
QAFM perceived emotional involvement
ADHD 14.22 (2.77) 14.69 (3.11) F(1,82) = 0.14 ns
Significant others 12.69 (3.04) 12.49 (2.88) g2 \ 0.01
QAFM critical remarks
ADHD 20.76 (8.08) 18.84 (6.54) F(1,80) = 11.55 p \ 0.01
Significant others 23.19 (7.89) 20.95 (6.75) g2 = 0.13
QAFM emotional overinvolvement
ADHD 18.51 (6.36) 18.49 (6.21) F(1,80) = 1.04 ns
Significant others 21.68 (6.41) 20.76 (5.46) g2 = 0.01
Beck depression inventory
ADHD 18.81 (12.41) 15.39 (10.86) F(1,79) = 8.00 p \ 0.01
Significant others 9.18 (8.09) 7.65 (7.80) g2 = 0.09
Beck anxiety inventory
ADHD 14.37 (11.43) 12.00 (10.39) F(1,79) = 5.39 p \ 0.05
Significant others 6.95 (6.72) 6.05 (593) g2 = 0.06
Perceived stress scale
ADHD 32.85 (9.67) 30,39 (9.75) F(1,78) = 4.92 p \ 0.05
Significant others 23.85 (6.16) 22.08 (8.53) g2 = 0.06
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some respects (such as willingness to participate in a
similar program in the future). Moreover, treatment com-
pletion was better among adults with ADHD (84.3 %) than
among their significant others (73.7 %). Therefore, the
acceptability of the program for both groups was judged to
be one of the main focuses for further development of the
PEGASUS program.
One of the main goals of the intervention is to provide the
participants with evidence- based knowledge concerning
ADHD in order to reduce stigma, prejudices, and discrimi-
nation (Mueller et al. 2012) and to increase understanding of
the disorder and thereby improve the relationship between
the co-participants (i.e., the adult individual with ADHD and
his/her participating significant other[s]) (Goodman 2007;
Moss et al. 2007). Knowledge pertaining to ADHD was
improved from pre- to post-intervention in both groups.
Moreover, the measurement of expressed emotions indicated
a reduction in critical remarks directed toward the co-par-
ticipant in the course. In addition, we observed a positive
effect on psychological well-being (symptoms of depres-
sion, anxiety, and perceived stress) in the entire study group,
i.e., both in adults with ADHD and their significant others.
The reduced subjective burden on the participating signifi-
cant others may reflect a better knowledge of ADHD and
acceptance of ADHD as a disability.
An important goal of the development and evaluation of
all new psychological interventions is to ensure that the
intervention is not harmful to the participants. A focus on
possible harmful effects has not been a central aspect of
research on psychological interventions, although emerging
data indicate that several psychological treatments may
produce harm in a significant number of individuals (Li-
lienfeld 2007). Therefore, attention to the well-accepted
principle primum non nocere (‘‘first, do no harm’’) should
also be increased among psychologists (ibid). This may be
especially true regarding psychological treatments for
adults with ADHD, since early studies (Ratey et al. 1992)
on clinical characterization of adult ADHD indicate that
traditional psychological treatment ‘‘had little beneficial
effects and aggravated problems of self-esteem.’’. Indeed,
the only study published hitherto on a diagnosis-specific
psychoeducational program for adults with ADHD (Wig-
gins et al. 1999) showed a negative effect on self-esteem.
The authors speculated that the decrease in self-esteem may
be a temporary effect of increased awareness of the diffi-
culties and problems in everyday life, as well as an under-
standing of the effort that is needed to manage everyday life
while having ADHD. On the contrary, our goal in the
PEGASUS program was to increase awareness of problems,
as well as the needed coping strategies, while preserving
self-esteem. Thus, we used techniques from contextual
behavior therapies to promote both coping/change and
acceptance in a dialectical, constructive manner. We mea-
sured potential effects on self-esteem using the same
questionnaire as Wiggins et al. and did not observe any
significant effect of the PEGASUS program on self-esteem
(i.e., the increase in self-esteem approached, but did not
reach, statistical significance). In the further development of
the program, the issue of self-esteem has been focused on
continuously. As pointed out in the first study focusing on
psychological treatments for adults with ADHD, ‘‘the crit-
ical point for practitioners is that the requirements of
treatment for patients with attentional deficits go far beyond
just simple treatment of the neurological problem. One
needs to consider the ramifications of the disorder in all
aspects of the patient’s life: vocational, educational, social,
and psychological.’’ (Ratey et al. 1992). A crucial goal for
the PEGASUS program is to provide the participants with
the same information, in a way that does not cause harm but
hopefully strengthens the participant’s self-esteem and, in
the long run, quality of life.
Due to the open study design, the results from the effi-
cacy-related measures should be considered to be pre-
liminary and interpreted cautiously. In an open study, the
conventional alpha level of p \ 0.05 may be considered as
rather lenient since the observed effects may partly be
related to regression toward the mean at T2/T3. Thus, the
randomized controlled study currently under progress will
provide more information on the efficacy of the treatment
program. Additional limitations were the amount of miss-
ing data, especially at the scheduled follow-up of 6 months
after the program, and therefore missing long-term follow-
up data. Moreover, we observed possible ceiling effects
(the knowledge quiz) and floor effects (measures of
depression and anxiety among significant others) on some
of the outcome measures. Bearing these limitations in
mind, the overall pattern in the results indicated promising
effects of participation in the PEGASUS program and
encouraged us to continue with the project and initiate a
randomized controlled trial. However, before entering the
RCT phase, the treatment materials were subjected to a
thorough adaptation based on feedback from the partici-
pants as well as the involved course coordinators.
Table 5 Results of repeated measures ANOVAs from baseline to

















1.08 (0.76) 0.80 (0.55) F(1,39) = 8.73 p \ 0.01
g2 = 0.18
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In summary, a new manualized psychoeducational pro-
gram for adults with ADHD and their significant others,
PEGASUS (Hirvikoski et al. 2013a), was evaluated in an
open study design. The results regarding feasibility, treat-
ment satisfaction, and preliminary efficacy were promising.
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